Skip to main content

Canada's $38M Innovation Effort Includes 'Omics, Biomedicine

NEW YORK (GenomeWeb News) — The Canada Foundation for Innovation has awarded millions in funding for biomedical, genomics, and genetics research to institutions and investigators under a C$45 million (US$38 million) investment aimed at developing scientific infrastructure and attracting researchers to Canadian institutions. 
Dozens of institutes across the nation were recently awarded grants for a wide range of studies as part of an effort to pump energy into Canadian biomedical research and other fields “at a time of intense international competition for knowledge workers,” said the CFI.
“The Government of Canada understands that advances in science and technology are essential to strengthen the competitiveness of Canada’s economy,” said Tony Clement, minister of industry and minister responsible for the CFI. Clement explained that the funds will help “researchers and innovators in developing new ideas by investing in infrastructure to conduct world-class research.”
The total investment of C$45.4 million was awarded under two funds, with C$38.2 million being given under the Leaders Opportunity Fund, and the remaining C$7.2 million under the Infrastructure Operating Fund.
McGill University received C$1.2 million for several projects including studies of cancer genes and microbial ecosystems. Simon Fraser University received C$705,000, with funds going to an institute for pharmacogenomics, bioinformatics, and drug discovery, as well as a molecular and cellular biology lab.
The University of Montreal reeled in C$3.9 million for whole-genome population genetics studies, an RNA engineering laboratory, and research into the functional and structural analysis of multi-protein complexes, among other efforts.
The University of Alberta received C$1.1 million, which includes money for transgenic zebrafish protein studies, studies of plant genetics, and funding for a mass spectrometry facility.
A full list of the institutes and programs receiving funding under the CFI program is available here

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.